Patent details

EP2167033 Title: ONCE DAILY ORAL DOSAGE FORM COMPRISING TACROLIMUS

Basic Information

Publication number:
EP2167033
PCT Application Number:
DK2008050130
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP087488292
PCT Publication Number:
WO2008145143
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ONCE DAILY ORAL DOSAGE FORM COMPRISING TACROLIMUS
French Title of Invention:
FORME PHARMACEUTIQUE ORALE À ADMINISTRER UNE FOIS PAR JOUR COMPORTANT DU TACROLIMUS
German Title of Invention:
TACROLIMUS ENTHALTENDE ORALE DOSISFORM ZUR EINMAL TÄGLICHEN EINNAHME
SPC Number:

Dates

Filing date:
30/05/2008
Grant date:
19/04/2017
EP Publication Date:
31/03/2010
PCT Publication Date:
04/12/2008
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
19/04/2017
EP B1 Publication Date:
19/04/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
30/05/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
13/02/2025
 
 

Name:
VELOXIS PHARMACEUTICALS, INC
Address:
2000 Regency Parkway, Suite 500, 27518,, Cary, NC , United States (US)

History of Owners

From:
13/02/2025
To:
13/02/2025

Name:
VELOXIS PHARMACEUTICALS A/S
Address:
c/o Bech- Bruun, Langelinie Alie 3 5, 21 00, Copenhagen , Denmark (DK)

From:
19/04/2017
To:
13/02/2025

Name:
Veloxis Pharmaceuticals A/S
Address:
Agern Allé 24, 4.2, 2970 Hørsholm, Denmark (DK)

Agent

Name:
Office FREYLINGER S.A.
From:
12/07/2017
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
LADEMANN, Anne-Marie
Address:
Denmark (DK)

2

Name:
NORLING, Tomas
Address:
Denmark (DK)

3

Name:
HOLM, Per
Address:
Denmark (DK)

Priority

1

Priority Number:
200700783
Priority Date:
30/05/2007
Priority Country:
Denmark (DK)

2

Priority Number:
200701573
Priority Date:
07/11/2007
Priority Country:
Denmark (DK)

Classification

IPC classification:
A61K 9/00; A61K 9/16; A61K 9/20; A61K 9/28; A61K 9/48; A61K 31/436; A61K 47/10;

Publication

Bulletin

1

Bulletin Heading:
CO
Bulletin edition number:
2025/04
Publication date:
04/03/2025
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

2

Bulletin Heading:
CO
Bulletin edition number:
2025/04
Publication date:
04/03/2025
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

Issue number:
201716
Publication date:
19/04/2017
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name/address
Deed Number:
RC20250000053A
Date Registered:
13/02/2025
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
KIRKPATRICK
Journal Edition Number:
Text:
Change of address
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
VELOXIS PHARMACEUTICALS A/S
Address:
c/o Bech- Bruun, Langelinie Alie 3 5, 21 00, Copenhagen , Denmark (DK)

Removed Pledgee

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20250000054A
Date Registered:
13/02/2025
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
KIRKPATRICK
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
VELOXIS PHARMACEUTICALS, INC
Address:
2000 Regency Parkway, Suite 500, 27518,, Cary, NC , United States (US)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
01/06/2026
Annual Fee Number:
19
Annual Fee Amount:
281 Euro
Expected Payer:
Last Annual Fee Payment Date:
16/05/2025
Last Annual Fee Paid Number:
18
Last Annual Fee Paid Amount:
262 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
12/07/2017 Power Of Attorney 1
19/07/2017 Outgoing Correspondence 1
13/02/2025 Request For Change 3
13/02/2025 Outgoing Correspondence 1
13/02/2025 Request For Change 3
13/02/2025 Outgoing Correspondence 1